In compliance with current regulations, let us know which audience you belong to:
Anterior Segment
— ABOUT OCULAR SURFACE
Our unparalleled expertise and scientific leadership in ophthalmology are anchored in the diagnosis and treatment of anterior segment conditions.
From managing MGD/DED and Sjögren’s Syndrome to treating Chalazia and Blepharitis, we consistently set the industry benchmark with our innovative LM® LLLT and OPE® IPL technologies.
While we are expanding into posterior segment treatments, our commitment to excellence in anterior segment care remains unmatched.
MGD/DED >
Dry Eye Disease (DED) from Meibomian Gland Dysfunction (MGD) occurs in over 86% of cases due to excessive tear evaporation. Blocked MG cause insufficient oil in the tear film, leading to quicker evaporation, ocular surface damage, and discomfort.
Blepharitis >
Blepharitis is inflammation of the eyelid margins. Anterior blepharitis involves bacterial overgrowth and Demodex, while MGD causes posterior blepharitis. Viral factors and seborrheic diseases can lead to chronic blepharitis, often linked with DED.
Chalazion >
Chalazion, a common eyelid lesion, results from a blocked MG, causing lipid buildup and inflammation. Prompt treatment is essential to prevent complications or styes.
Post-Blepharoplasty >
Blepharoplasty is eyelid surgery to remove excess skin and fat, improving appearance and vision. A common postoperative complication is dry eye, particularly in patients with preexisting symptoms.
Rosacea >
Rosacea is a chronic skin disease causing facial redness and sometimes affecting the eyes (ocular rosacea). Symptoms include red, burning, or watery eyes, swollen eyelids, and clogged eyelid glands.
Demodex >
Demodex, a common ectoparasite in eyelash follicles, is linked to rosacea, chalazion, stye, and chronic blepharitis. It is often missed in routine exams, causing unclear diagnoses and ineffective treatments.
Stye >
A stye, or hordeolum, is a common eyelid gland infection causing a lump, typically due to Staphylococcus bacteria. Internal hordeolums infect Meibomian glands, while external ones form near lash roots.
Sjogren’s Sindrome >
Sjogren’s Syndrome is an autoimmune disease where the immune system attacks glands that lubricate the eyes and mouth, causing dry eyes. Our technologies stimulate eyelid mucous membranes, providing efficient, painless, non-surgical treatment, ensuring maximum patient satisfaction.
Cataract & Refractive Surgery >
Eye surgery often worsens tear dysfunction, with two-thirds of patients developing dry eye. Nearly 40% develop dry eye after cataract surgery, lasting up to a year. Accurate biometry and keratometry are crucial as ocular surface disorders cause 10% of refractive errors. Preoperative dry eye treatment improves outcomes and prevents complications like endophthalmitis.
LM® LLLT, short for Light Modulation® Low-level Light Therapy, is a unique photobiomodulation technology enabling treatment of both anterior segment conditions (DED, Chalazion etc) and posterior segment conditions (dAMD and CSC).
Optimal Power Energy® is Espansione’s patented evolution of Intense Pulsed Light technology. It leverages a polychromatic light to treat ocular surface conditions, such MGD/DED, Blepharitis, Rosacea or Sjogren’s Syndrome.
Our flagship solution for comprehensive eye care leverages both LM® LLLT and OPE® IPL technologies, providing optimal management for a wide range of anterior and posterior segment conditions.
The best professional solution to take advantage of LM® LLLT technology was tailored to effectively manage anterior segment conditions including DED/MGD and more.
Miniaturizing our Red LM® LLLT technology into such a portable, small package was a challenge we faced with the intention of providing operators and patients with a convenient yet powerful solution to benefit from light-based therapy wherever they feel like.
The easiest, quickest, certified medical device to screen for ocular surface conditions. Built from the ground-up to be modular and actionable.